First-line immune-based combinations or sunitinib in favorable-risk metastatic renal cell carcinoma: a real-world retrospective comparison from the ARON-1 study.
Saved in:
| Title: | First-line immune-based combinations or sunitinib in favorable-risk metastatic renal cell carcinoma: a real-world retrospective comparison from the ARON-1 study. |
|---|---|
| Authors: | Roviello G; Department of Health Sciences, Section of Clinical Pharmacology and Oncology, University of Florence, Viale Pieraccini 6, 50139, Florence, Italy., Molina-Cerrillo J; Department of Medical Oncology, Hospital Ramón y Cajal, Madrid, Spain. javier.molinace@gmail.com.; Alcalá University, Madrid, Spain. javier.molinace@gmail.com., Massari F; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Via Albertoni 15, Bologna, Italy.; Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy., Cerbone L; Department of Medical Oncology, San Camillo Forlanini Hospital, Rome, Italy., Fiala O; Department of Oncology and Radiotherapeutics, Faculty of Medicine and University Hospital in Pilsen, Charles University, Pilsen, Czech Republic.; Faculty of Medicine in Pilsen, Biomedical Center, Charles University, Pilsen, Czech Republic., Fornarini G; IRCCS Ospedale Policlinico San Martino, Genoa, Italy., Monteiro FSM; Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil.; Oncology and Hematology Department, Hospital Sirio-Libanês, SGAS 613 Lote 94, Brasília, DF, Brazil., Cattrini C; Department of Medical Oncology, 'Maggiore Della Carità' University Hospital, 28100, Novara, Italy., Landmesser J; Klinik Für Urologie, Ratzeburger Allee 160, 23538, Lübeck, Germany., Messina C; Oncology Unit, A.R.N.A.S. Civico, Palermo, Italy., Zgura A; Department of Oncology-Radiotherapy, Prof. Dr. Alexandru Trestioreanu Institute of Oncology, 'Carol Davila', University of Medicine and Pharmacy, Bucharest, Romania., Rebuzzi SE; Ospedale San Paolo, Medical Oncology, 17100, Savona, Italy.; Department of Internal Medicine and Medical Specialties (Di.M.I.), University of Genoa, Genoa, Italy., Soares A; Latin American Cooperative Oncology Group - LACOG, Porto Alegre, Brazil.; Hospital Israelita Albert Einstein, São Paulo, SP, Brazil., Carrozza F; Department of Medical Oncology, AUSL Della Romagna, Ospedale Civile Degli Infermi, Faenza, Italy., Ansari J; Medical Oncology, Tawam Hospital, Al Ain, United Arab Emirates., Grillone F; SOC Oncologia PO Pugliese-Ciaccio Azienda Ospedaliera Universitaria Renato Dulbecco, Catanzaro, Italy., Küronya Z; Department of Genitourinary Medical Oncology and Clinical Pharmacology, National Institute of Oncology, Budapest, Hungary., Incorvaia L; Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, University of Palermo, Palermo, Italy., Bhuva D; Department of Medical Oncology, Army Hospital Research and Referral, New Delhi, India., Ortega C; Division of Oncology, Institute for Cancer Research and Treatment, Asl Cn2 Alba-Brà, 12051, Alba-Brà, Italy., Nasso C; Medical Oncology, Ospedale Santa Corona, 17027, Pietra Ligure, Italy., Kanesvaran R; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore., Zampiva I; Section of Innovation Biomedicine - Oncology Area, Department of Engineering for Innovation Medicine (DIMI), University of Verona, Verona, Italy., Porta C; Interdisciplinary Department of Medicine, University of Bari 'Aldo Moro' and Division of Medical Oncology, A.O.U. Consorziale Policlinico Di Bari, Piazza Giulio Cesare, 11, 70124, Bari, Italy., Buti S; Medical Oncology Unit, University Hospital of Parma - Department of Medicine and Surgery, University of Parma, Parma, Italy., Santoni M; Oncology Unit, Macerata Hospital, Macerata, Italy. |
| Source: | Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2025 Jan 03; Vol. 74 (2), pp. 65. Date of Electronic Publication: 2025 Jan 03. |
| Publication Type: | Journal Article; Multicenter Study; Comparative Study |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1432-0851 |
|---|---|
| DOI: | 10.1007/s00262-024-03897-x |
